← ANALYSTS · TIPRANKS
Alex Thompson CFA · Stifel Nicolaus
Hits
73%
153 of 209 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+50.6%
Over a year after the rating, TipRanks’ measure
Our companies rated now
20
Buy / hold / sell: 17 / 3 / 0
Upside of the analyst’s targets
+145.1%
Average over 20 current targets, to the last price
The market’s answer to the ratings
−1.3%
Day-0 move against SPY in the rating’s direction, average over 8 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 8on TipRanks 09:05 | ARGXArgenx Se · $51.7B | Reiterated | Buy | $1,282 | +56.5% | −11.4%next day +0.2% · 5 days +3.7% | ↗ |
| Sep 22on TipRanks Sep 23 06:14 | CLDXIWMCelldex · $2.3B | Assigned | Buy | $58.00 → $68.00+17.2% | +147.0% | −11.5%next day −6.4% · 5 days −4.4% | ↗ |
| Sep 22on TipRanks 06:30 | KYMRIWMKymera Therapeutics · $9.0B | Reiterated | Buy | $132 → $152+15.2% | +45.1% | +3.7%next day −4.7% · 5 days −8.3% | ↗ |
| Sep 17on TipRanks Sep 16 16:20 | ROIVRoivant Sciences · $25.0B | Initiated | Buy | $51.00 | +52.1% | −0.1%next day −0.7% · 5 days −10.5% | ↗ |
| Sep 9on TipRanks 10:35 | EVMNIWMEvommune, Inc. · $215M | Reiterated | Buy | $30.00 | +480.3% | −16.7%next day −2.0% · 5 days −12.5% | ↗ |
| Sep 1on TipRanks 22:05 | ASNDAscendis Pharma · $13.9B | Reiterated | Buy | $326 | +44.7% | +2.3%next day +0.4% · 5 days −1.3% | ↗ |
| Aug 16on TipRanks 13:50 | SEPNIWMSepterna, Inc. · $1.7B | Reiterated | Buy | $43.00 → $46.00+7.0% | +26.5% | −0.2%next day −0.2% · 5 days −7.1% | ↗ |
| Aug 13on TipRanks 11:35 | JBIOIWMJade Biosciences · $855M | Reiterated | Buy | $40.00 | +197.0% | +1.9%next day +4.0% · 5 days −8.9% | ↗ |
| Aug 13on TipRanks 11:35 | SYREIWMSpyre Therapeutics · $7.3B | Reiterated | Buy | $123 | +53.9% | −2.8%next day +1.9% · 5 days +7.8% | ↗ |
| Aug 13on TipRanks 11:35 | ALMSIWMAlumis Inc. · $842M | Reiterated | Buy | $44.00 | +619.0% | −5.2%next day +3.9% · 5 days −4.4% | ↗ |
| Aug 13on TipRanks 11:35 | CGEMIWMCullinan Management · $901M | Reiterated | Buy | $28.00 | +116.6% | −0.5%next day +3.8% · 5 days +10.8% | ↗ |
| Aug 13on TipRanks 11:35 | DNTHIWMDianthus Therapeutics · $4.2B | Reiterated | Buy | $133 | +84.5% | −3.2%next day +6.0% · 5 days +1.9% | ↗ |
| Aug 13on TipRanks 11:35 | VRDNIWMViridian Therapeutics · $2.2B | Reiterated | Buy | $40.00 | +110.2% | −4.6%next day +0.6% · 5 days +13.4% | ↗ |
| Aug 11on TipRanks Aug 12 22:05 | IMVTIWMImmunovant · $5.8B | Reiterated | Buy | $49.00 → $57.00+16.3% | +113.2% | +2.9%next day +3.8% · 5 days +8.6% | ↗ |
| Aug 9on TipRanks 12:37 | TVTXIWMTravere Therapeutics · $5.0B | Reiterated | Hold | $43.00 → $62.00+44.2% | +25.0% | −0.7%next day −0.8% · 5 days +4.4% | ↗ |
| Jul 6on TipRanks 01:55 | PALIIWMPalisade Bio · $268M | Reiterated | Buy | $5.00 | +254.6% | −3.7%next day +2.4% · 5 days −7.1% | ↗ |
| Jun 29on TipRanks 04:30 | ORKAIWMOruka Therapeutics · $4.9B | Reiterated | Buy | $150 | +108.5% | +0.4%next day +2.1% · 5 days −9.5% | ↗ |
| May 15on TipRanks May 17 22:08 | AVTXIWMAvalo Therapeutics · $644M | Reiterated | Buy | $36.00 → $39.00+8.3% | +246.1% | −5.5%next day −8.8% · 5 days −8.7% | ↗ |
| May 8on TipRanks May 10 22:05 | ACRSIWMAclaris Therapeutics · $514M | Reiterated | Hold | $4.00 | +22.0% | +0.6%next day +0.2% · 5 days −8.5% | ↗ |
| Mar 1on TipRanks 14:10 | MLTXMoonLake Immunotherapeutics · $873M | Reiterated | Hold | $13.00 → $19.00+46.2% | +99.0% | +0.9%next day +0.9% · 5 days +4.8% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗